

Ethereum operates as a global smart contract platform secured by validators and Layer 2 scaling solutions, but faces risks from network upgrades, centralization and competition.
Researchers propose functional encryption to enforce Bitcoin spending constraints via restricted signing keys, sidestepping contentious soft fork battles.
DeFi & On-ChainThe restaking protocol's native asset fell 48 percent over four weeks, significantly underperforming Bitcoin and Ether, as EigenLayer collateral declined 28.5 percent.

Nearly half the index's value now derives from AI stocks or suppliers, surpassing the 25-35% concentration seen in past market bubbles and creating acute portfolio risk for conservative investors.
Macro & RatesRecord low pending sales and pandemic-worst building permits are eroding Fed rate-hike odds and pushing Treasury yields lower across the curve.
Eli Lilly's acquisition of the immunology-focused biotech adds to a record year of deal-making as the pharma giant prioritizes external growth in oncology.
“Eli Lilly & Co. agreed to acquire Calytrix Bio Inc. for up to $1.5 billion, the latest deal in a $32 billion acquisition spending spree in 2026. The transaction targets therapies in cancer and immunol”


Real-time crypto and equity data, quantitative signals, and the market intelligence that moves portfolios — all in one terminal. Built for investors who can’t afford to be late.